NCT02974374View on ClinicalTrials.gov

Single Dose of PF-06835919 Escalation Study in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Non-alcoholic Fatty Liver Disease
Interventions
DRUG

PF-06835919

Single or repeated, escalating dose

OTHER

Placebo

Single or repeated, escalating dose

Trial Locations (1)

06511

Pfizer New Haven Clinical Research Unit, New Haven

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT02974374 - Single Dose of PF-06835919 Escalation Study in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter